CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving treatment options for children with relapsed solid tumors by developing and testing new drugs tailored to the genetic profiles of these tumors. The initiative aims to create well-characterized patient-derived models to enhance preclinical drug testing and increase the chances of succes…
Cancer remains the leading cause of disease-related death in children.
For the ~25% of children who experience relapses of their malignant solid tumors, usually after very intensive first-line therapy, curative treatment options are scarce.
Preclinical drug testing to identify promising treatment options that match the molecular make-up of the tumor is hampered by the facts that i) molecular genetic data on pediatric solid tumors from relapsed patients and thus our understanding of tumor evoluti…
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER ASSOCIATION
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
France, Villejuif
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
